Murray Andrea A

Show results for

Unknown (14)
Transcriptomics (2)
Metabolomics (1)

Organisms

Drosophila melanogaster (1)
Mus musculus (1)

Repository

biostudies-arrayexpress (2)
MetaboLights (1)

Technology Type

Mass spectrometry (1)

Instrument Platform

6520 Q-TOF LC/MS (Agilent) (1)

Publication Date

2016 (2)
2010 (1)

Metabolite Name

(+)-.alpha.-tocopherol (1)
(+)-catechin (1)
(+)-isocorydine (1)
(-)-.alpha.-kainic acid (1)
(-)-epigallocatechin (1)
(-)-myrtenol (1)
(2e,4e)-hexa-2,4-dienoic acid (1)
(2e,4e,12z)-n-(2-methylpropyl)octadeca-2,4,12-trienamide (1)
(3.beta.,5.alpha.)-4,4-dimethylcholesta-8,14,24-trien-3-ol (1)
(4r)-4-((1r,3s,5s,7r,9s,10s,12s,13r,14s,17r)-1,3,7,12-tetrahydroxy-10,13-dimethylhexadecahydro-1h-cyclopenta[a]phenanthren-17-yl)pentanoic acid (1)
(r)-butyrylcarnitine (1)
(s)-cotinine n-oxide (1)
.alpha.-L-Glu-L-Tyr (1)
.alpha.-ionone (1)
.beta.-muricholic acid (1)
.beta.-nicotinamide adenine dinucleotide, reduced(NADH) (1)
.beta.-sitosterol (1)
.beta.-thujaplicin (1)
.delta.-dodecalactone (1)
.gamma.-aminobutyric acid (1)
.gamma.-l-glu-.epsilon.-l-lys (1)
.omega.-3 arachidonic acid (1)
1,2-di-(9z,12z,15z-octadecatrienoyl)-sn-glycero-3-phosphocholine (1)
1,2-dilinolenoyl-sn-glycero-3-phosphoethanolamine (1)
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (1)
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-n,n-dimethyl (1)
1,2-dioleoyl-sn-glycerol (1)
1,2-dipalmitoleoyl-sn-glycero-3-phosphocholine (1)
1,2-dipentadecanoyl-sn-glycero-3-phosphoethanolamine (1)
1,5-pentanediamine (1)

Study type

Transcription profiling by array (2)

Release Date

2016 (2)
2025 (2)
2023 (2)
2010 (1)
2024 (1)
2022 (1)
2021 (1)
2020 (1)
2015 (1)
2014 (1)
2013 (1)
2012 (1)
2011 (1)

Previous page
1 / 2
You're on page 1
page 2
Next page

Sort by:

Relevance

Page size

Patterns of Symptom Change in Behaviors and Cognitions During 10-Session Cognitive Behavioral Therapy (CBT-T) for Non-Underweight Eating Disorders.

Not available

S-EPMC12354263 | biostudies-literature

Metabolomic profiling of Fraxinus excelsior genotypes tolerant or susceptible to ash dieback disease reveals changes in iridoid glycosides

European common ash, Fraxinus excelsior L., is currently threatened by Ash dieback (ADB) caused by the fungus, Hymenoscyphus fraxineus. To detect and identify metabolites that may be products of pathways important in contributing to resistance against H. fraxineus we performed untargeted metabolomic...

2016-11-09 | MTBLS372 | MetaboLights

RNAi of Drosophila dTip60 in SL2 cells to investigate regulation of gene expression by the histone acetyltransferase dTip60

We used microarrays to detail the global gene expression changes following RNAi knock-down of dTip60 in Drosophila SL2 cells Experiment Overall Design: We compared SL2 cells treated with dTip60-RNAi with SL2 cells mock-treated with eGFP-RNAi to determine global gene expression changes by microarray ...

ORGANISM(S): Drosophila melanogaster

2010-01-23 | E-GEOD-13878 | biostudies-arrayexpress

The role of Gaq in MLL leukemogenesis

Beta-catenin has a central role for self-renewal of leukemic stem cells in Mixed Lineage Leukemia (MLL)-arranged acute myeloid leukemia (AML), however its upstream modulators that can enhance this pathway remain largely unexplored. Through genome-wide gene expression analysis, we identified a previo...

ORGANISM(S): Mus musculus

2016-02-25 | E-MTAB-4078 | biostudies-arrayexpress

Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia: A Randomized Clinical Trial.

Not available

S-EPMC11615712 | biostudies-literature

Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials.

Not available

S-EPMC10091180 | biostudies-literature

Search for supersymmetry in pp collisions at [Formula: see text] TeV in events with a single lepton, jets, and missing transverse momentum.

Not available

S-EPMC4370766 | biostudies-literature

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.